Click here to view our latest science success stories. It's important to reflect on the success of new medicines making patients lives significantly better.
One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health.
Boehringer Ingelheim is a global group of companies whose aim is to improve the lives of both humans and animals. Click here to find out more about us.
Metabolic Diseases About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases
Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers, livestock veterinarians, government officials and NGOs.
Fostering science via partnerships & collaborating is crucial for developing effective treatments which can transform patients lives. Find out more here.
Boehringer Ingelheim objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision.
Animal Health Global Innovation Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our